Livestock Industry Relies on AST for Infection Control

التعليقات · 11 الآراء

The Veterinary Antimicrobial Susceptibility Testing market is firmly positioned for sustained growth through 2032. The primary driver remains the indispensable need to combat antimicrobial resistance globally, making VAST solutions mandatory for effective Veterinary Antibiotic Stewardship

The global Veterinary Antimicrobial Susceptibility Testing (VAST) Indsutry is experiencing robust expansion, fundamentally driven by the escalating worldwide concern over Antimicrobial Resistance (AMR) and the increasing implementation of Veterinary Antibiotic Stewardship programs. These diagnostics are crucial for ensuring the appropriate and judicious use of antibiotics in animals, which directly impacts public health through the "One Health" approach.

The market’s foundational size was valued at USD 41.68 billion in 2024 and is projected to demonstrate strong growth over the forecast period. By the end of 2032, the market is expected to reach USD 62.72 billion, growing at a Compound Annual Growth Rate (CAGR) of 5.24% from 2024 to 2032.

Market Size and Data Forecast Year 2025

The momentum gained from regulatory pressures and technological adoption is set to continue into the immediate future. Based on the projected 5.24% CAGR, the global VAST market size is estimated to reach approximately USD 43.86 billion in 2025. This significant leap reflects the global efforts to standardize testing protocols and increase diagnostic testing penetration across both livestock and companion animal sectors, solidifying VAST as a vital segment of the broader veterinary diagnostics industry.

Get a Sample Report of Veterinary Antimicrobial Susceptibility Testing (VAST) Indsutry Forecast @https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-veterinary-antimicrobial-susceptibility-testing-marke

Segmentation Analysis and Key Trends

The VAST market can be segmented primarily by Product TypeAnimal Type, and End-User.

Product Segmentation

Historically, manual methods like disks and plates have held significant market share due to their cost-effectiveness and ease of implementation. However, the fastest growth is being witnessed in the Automated AST Instruments segment. These systems, which include instruments for automated identification and susceptibility testing, offer benefits like rapid turnaround times, high throughput capacity, and reduced risk of human error. This technological shift is essential for large reference laboratories and high-volume veterinary settings.

Animal Type Segmentation

The market is broadly divided into Production Animals (livestock such as cattle, poultry, and swine) and Companion Animals (pets). The Production Animals segment currently holds the largest market share, driven by intense farming practices, the economic necessity of preventing disease outbreaks, and stringent government regulations concerning food safety and antibiotic usage in the food chain. The Companion Animals segment, however, is projected to register a higher growth rate, fueled by rising pet ownership, increasing expenditure on pet healthcare, and the trend of treating pets as family members, leading to greater demand for sophisticated diagnostic tools.

Integrated Trends

A key trend accelerating market growth is the integration of Artificial Intelligence (AI) and advanced software solutions with AST platforms. AI-powered tools are being used to interpret resistance patterns, streamline lab workflows, and connect diagnostic data with Veterinary Antibiotic Stewardship programs. This digitalization enhances data accuracy and enables veterinarians to make faster, more informed treatment decisions, contributing directly to the global strategy for mitigating antimicrobial resistance.

Do you have any specific queries or need any Veterinary Antimicrobial Susceptibility Testing (VAST) Indsutry Submit your inquiry here @https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-veterinary-antimicrobial-susceptibility-testing-market

Competitive Landscape: Key Market Players

The global VAST market is characterized by the presence of both large, diversified healthcare corporations and specialized diagnostic providers. The competitive strategy often revolves around technological innovation, particularly in automated systems, and geographic expansion, especially into emerging Asia-Pacific markets.

The key players dominating the global veterinary antimicrobial susceptibility testing market include:

· BD (U.S.)

· 

· Synbiosis (U.S.)

· 

· Zhuhai DL Biotech Co., Ltd. (China)

· 

· Mast Group Ltd. (U.K.)

· 

· HiMedia Laboratories (India)

· 

· Thermo Fisher Scientific Inc. (U.S.)

· 

· Bio-Rad Laboratories, Inc. (U.S.)

· 

· Creative Diagnostics (U.S.)

· 

· Genefluidics, Inc. (U.S.)

· 

· ROSCO DIOGNISTICA (Germany)

· 

· Erba Mannheim (U.S.)

· 

· Liofilchem S.r.l. (Italy)

· 

· Alifax S.r.l. (Italy)

· 

· MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)

· 

· BIOMÉRIEUX (France)

· 

· Merck KGaA (U.S.)

· 

· Danaher Corporation (U.S.)

· 

· Accelerate Diagnostics, Inc. (U.S.)

· 

· NuMedii, Inc. (U.S.)

Get A Buy Now Report Veterinary Antimicrobial Susceptibility Testing (VAST) Indsutry Forecast @https://www.databridgemarketresearch.com/checkout/buy/global-veterinary-antimicrobial-susceptibility-testing-market/compare-licence

Future Outlook

The Veterinary Antimicrobial Susceptibility Testing market is firmly positioned for sustained growth through 2032. The primary driver remains the indispensable need to combat antimicrobial resistance globally, making VAST solutions mandatory for effective Veterinary Antibiotic Stewardship. The market’s evolution will be defined by the shift toward automation, the increasing role of AI, and the continuous need to provide faster, more accurate results to veterinary professionals working with both production and companion animals. As regulatory oversight tightens and public awareness of the 'One Health' link between animal and human well-being increases, the demand for sophisticated VAST diagnostics will only intensify, underscoring its critical role in the future of veterinary medicine and global health security.

About Us:

Data Bridge is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact :

Data Bridge Market Research Private Ltd .

3665 Kingsway - Suite 300 Vancouver BC V5R 5W2 Canada

+1 614 591 3140 (US)

+44 845 154 9652 (UK)

Email: [email protected]

Website: https://www.databridgemarketresearch.com

 

التعليقات